• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表观横向弛豫率(R2)能否评估局部晚期鼻咽癌同期放化疗的疗效?初步经验。

Can the apparent transverse relaxation rate (R2) evaluate the efficacy of concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma? a preliminary experience.

机构信息

Department of Radiology, Changzhou Cancer Hospital of Soochow University, 68 Honghe Road, Changzhou, 213000, Jiangsu, PR China.

出版信息

BMC Med Imaging. 2023 Jun 1;23(1):69. doi: 10.1186/s12880-023-01029-y.

DOI:10.1186/s12880-023-01029-y
PMID:37264331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10236599/
Abstract

BACKGROUND

The use of the apparent transverse relaxation rate (R2) in nasopharyngeal carcinoma (NPC) has not been previously reported in the literature. The aim of this study was to investigate the role of the R2 value in evaluating response to concurrent chemoradiotherapy (CCRT) in patients with NPC.

METHODS

Forty-one patients with locoregionally advanced NPC confirmed by pathology were examined by blood oxygenation level-dependent (BOLD) magnetic resonance imaging (MRI) before and after CCRT, and conventional MRI was performed 3 months after the completion of CCRT. All patients were divided into a responding group (RG) and a nonresponding group (NRG), according to MRI findings 3 months after the end of treatment. The R2 values before (R2*) and after (R2) CCRT and the ΔR2 (ΔR2=R2 - R2) were calculated in the tumor.

RESULTS

Among the 41 patients, 26 were in the RG and 15 were in the NRG. There was no statistical difference in the R2 between RG and NRG (P = 0.307); however, there were significant differences in R2 and ΔR2 (P < 0.001). The area under the curve of R2 and ΔR2 for predicting the therapeutic response of NPC was 0.897 and 0.954, respectively, with cutoff values of 40.95 and 5.50 Hz, respectively.

CONCLUSION

The R2 value can be used as a potential imaging indicator to evaluate the therapeutic response of locoregionally advanced NPC.

摘要

背景

目前文献中尚未报道过鼻咽癌细胞(NPC)表观横向弛豫率(R2)的应用。本研究旨在探讨 R2 值在评估 NPC 患者同步放化疗(CCRT)反应中的作用。

方法

对 41 例经病理证实的局部晚期 NPC 患者在 CCRT 前后进行血氧水平依赖(BOLD)磁共振成像(MRI)检查,并在 CCRT 完成后 3 个月进行常规 MRI 检查。所有患者根据治疗结束后 3 个月的 MRI 结果分为反应组(RG)和非反应组(NRG)。计算肿瘤在 CCRT 前后的 R2 值(R2*和 R2)和 R2 变化值(ΔR2=R2-R2)。

结果

在 41 例患者中,26 例为 RG,15 例为 NRG。RG 和 NRG 之间的 R2 值无统计学差异(P=0.307);然而,R2 和 ΔR2 值有显著差异(P<0.001)。R2 和 ΔR2 预测 NPC 治疗反应的曲线下面积分别为 0.897 和 0.954,截断值分别为 40.95 和 5.50 Hz。

结论

R2 值可作为评估局部晚期 NPC 治疗反应的潜在影像学指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc5/10236599/bb148b666cb9/12880_2023_1029_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc5/10236599/09abeeecbfac/12880_2023_1029_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc5/10236599/fb244d42150d/12880_2023_1029_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc5/10236599/bb148b666cb9/12880_2023_1029_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc5/10236599/09abeeecbfac/12880_2023_1029_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc5/10236599/fb244d42150d/12880_2023_1029_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc5/10236599/bb148b666cb9/12880_2023_1029_Fig3_HTML.jpg

相似文献

1
Can the apparent transverse relaxation rate (R2) evaluate the efficacy of concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma? a preliminary experience.表观横向弛豫率(R2)能否评估局部晚期鼻咽癌同期放化疗的疗效?初步经验。
BMC Med Imaging. 2023 Jun 1;23(1):69. doi: 10.1186/s12880-023-01029-y.
2
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial.新辅助化疗后序贯同步放化疗与单纯同步放化疗治疗局部晚期鼻咽癌的III期多中心随机对照试验
Eur J Cancer. 2017 Apr;75:14-23. doi: 10.1016/j.ejca.2016.12.039. Epub 2017 Feb 16.
3
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial.诱导化疗后同期放化疗与单纯同期放化疗治疗局部晚期鼻咽癌:III 期多中心随机对照临床试验的长期结果。
Eur J Cancer. 2019 Sep;119:87-96. doi: 10.1016/j.ejca.2019.07.007. Epub 2019 Aug 16.
4
MRI-Based Deep-Learning Model for Distant Metastasis-Free Survival in Locoregionally Advanced Nasopharyngeal Carcinoma.基于MRI的局部晚期鼻咽癌无远处转移生存期深度学习模型
J Magn Reson Imaging. 2021 Jan;53(1):167-178. doi: 10.1002/jmri.27308. Epub 2020 Aug 9.
5
MRI-based radiomics to compare the survival benefit of induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma: A multicenter study.基于 MRI 的放射组学比较诱导化疗联合同期放化疗与同期放化疗联合辅助化疗对局部晚期鼻咽癌的生存获益:一项多中心研究。
Radiother Oncol. 2022 Jun;171:107-113. doi: 10.1016/j.radonc.2022.04.017. Epub 2022 Apr 21.
6
Can 3D pseudo-continuous arterial spin labeling perfusion imaging be applied to predict early response to chemoradiotherapy in patients with advanced nasopharyngeal carcinoma?3D 伪连续动脉自旋标记灌注成像能否用于预测晚期鼻咽癌患者放化疗的早期反应?
Radiother Oncol. 2021 Jul;160:97-106. doi: 10.1016/j.radonc.2021.04.017. Epub 2021 May 2.
7
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.局部晚期鼻咽癌新辅助化疗后同期放化疗与同期放化疗后辅助化疗的比较。
BMC Cancer. 2018 Mar 27;18(1):329. doi: 10.1186/s12885-018-4210-3.
8
Meta-analysis of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma.同步放化疗治疗局部晚期鼻咽癌的Meta分析
J Cancer Res Ther. 2015 Oct;11 Suppl 2:C191-5. doi: 10.4103/0973-1482.168183.
9
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study.IVA 和 IVB 期鼻咽癌患者诱导化疗后同期放化疗与单纯同期放化疗的随机 III 期试验的最终结果 - 台湾癌症合作组(TCOG)1303 研究。
Ann Oncol. 2018 Sep 1;29(9):1972-1979. doi: 10.1093/annonc/mdy249.
10
Gemcitabine and cisplatin versus docetaxel and cisplatin as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma from non-endemic area of China.吉西他滨和顺铂与多西他赛和顺铂作为诱导化疗,随后在非中国鼻咽癌高发地区进行同期放化疗治疗局部晚期鼻咽癌。
J Cancer Res Clin Oncol. 2020 Sep;146(9):2369-2378. doi: 10.1007/s00432-020-03229-3. Epub 2020 May 3.

本文引用的文献

1
Comparison of the pre-treatment functional MRI metrics' efficacy in predicting Locoregionally advanced nasopharyngeal carcinoma response to induction chemotherapy.比较预处理功能磁共振成像指标预测局部晚期鼻咽癌对诱导化疗反应的疗效。
Cancer Imaging. 2021 Nov 10;21(1):59. doi: 10.1186/s40644-021-00428-0.
2
Diffusion-weighted MRI for predicting treatment response in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis.弥散加权 MRI 预测鼻咽癌患者治疗反应的系统评价和荟萃分析。
Sci Rep. 2021 Sep 23;11(1):18986. doi: 10.1038/s41598-021-98508-5.
3
Prognostic and therapeutic evaluation of nasopharyngeal carcinoma by dynamic contrast-enhanced (DCE), diffusion-weighted (DW) magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS).
动态对比增强(DCE)、扩散加权(DW)磁共振成像(MRI)和磁共振波谱(MRS)在鼻咽癌中的预后和治疗评估。
Magn Reson Imaging. 2021 Nov;83:50-56. doi: 10.1016/j.mri.2021.07.003. Epub 2021 Jul 8.
4
Quantitative T2*-Weighted Imaging and Reduced Field-of-View Diffusion-Weighted Imaging of Rectal Cancer: Correlation of R2* and Apparent Diffusion Coefficient With Histopathological Prognostic Factors.直肠癌的定量T2*加权成像和缩小视野扩散加权成像:R2*及表观扩散系数与组织病理学预后因素的相关性
Front Oncol. 2021 May 24;11:670156. doi: 10.3389/fonc.2021.670156. eCollection 2021.
5
Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck.肿瘤缺氧与头颈部鳞状细胞癌对 PD-1 阻断的耐药性有关。
J Immunother Cancer. 2021 May;9(5). doi: 10.1136/jitc-2020-002088.
6
Value of T2 Mapping in the Dynamic Evaluation of Renal Ischemia-Reperfusion Injury.T2 映射在肾缺血再灌注损伤的动态评估中的价值。
Acad Radiol. 2022 Mar;29(3):376-381. doi: 10.1016/j.acra.2021.03.004. Epub 2021 Apr 6.
7
HIF-1α downregulation of miR-433-3p in adipocyte-derived exosomes contributes to NPC progression via targeting SCD1.脂肪细胞来源的外泌体中 HIF-1α 下调 miR-433-3p 通过靶向 SCD1 促进 NPC 的进展。
Cancer Sci. 2021 Apr;112(4):1457-1470. doi: 10.1111/cas.14829. Epub 2021 Feb 22.
8
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline.《CSCO/ASCO 鼻咽癌临床诊疗指南》:放化疗用于局部晚期鼻咽癌的根治性治疗
J Clin Oncol. 2021 Mar 1;39(7):840-859. doi: 10.1200/JCO.20.03237. Epub 2021 Jan 6.
9
Utility of Preoperative Blood-Oxygen-Level-Dependent Functional MR Imaging in Patients with a Central Nervous System Neoplasm.术前血氧水平依赖功能磁共振成像在中枢神经系统肿瘤患者中的应用。
Neuroimaging Clin N Am. 2021 Feb;31(1):93-102. doi: 10.1016/j.nic.2020.09.009.
10
Feasibility and reproducibility of T2 mapping and DWI for identifying malignant lymph nodes in rectal cancer.T2 mapping 和 DWI 鉴别直肠癌中恶性淋巴结的可行性和可重复性。
Eur Radiol. 2021 May;31(5):3347-3354. doi: 10.1007/s00330-020-07359-7. Epub 2020 Nov 13.